We performed Dunn’s post hoc tests for pairwise comparisons, which revealed pronounced differences in USP47 expression across various GC subgroups, including tumor invasiveness, lymph node metastasis, tumor stage, and tumor grade (Supplemental Figure 4). This evidence concerns the gene USP47 and neoplasm.